These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 7614530
1. The efficacy and safety of once-daily nifedipine administered without food: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate hypertension. Nifedipine Study Group. Glasser SP, Ripa SR, Allenby KS, Schwartz LA, Commins BM, Jungerwirth S. Clin Ther; 1995; 17(2):296-312. PubMed ID: 7614530 [Abstract] [Full Text] [Related]
2. The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension. Nifedipine Study Group. Glasser SP, Jain A, Allenby KS, Shannon T, Pride K, Pettis PP, Schwartz LA, MacCarthy EP. Clin Ther; 1995; 17(1):12-29. PubMed ID: 7758054 [Abstract] [Full Text] [Related]
3. Comparison of 24-hour ambulatory blood pressure data in hypertensive patients switched from nifedipine-GITS to nifedipine-CC. Wurdeman RL, Mooss AN, Mohiuddin SM, Lucas BD, Ryschon KL, Hilleman DE. Pharmacotherapy; 1999 Jan; 19(1):94-100. PubMed ID: 9917082 [Abstract] [Full Text] [Related]
4. Comparison of the efficacy and safety of nifedipine coat-core versus amlodipine in the treatment of patients with mild-to-moderate essential hypertension. Hypertension Study Group. Zidek W, Spiecker C, Knaup G, Steindl L, Breuer HW. Clin Ther; 1995 Jan; 17(4):686-700. PubMed ID: 8565032 [Abstract] [Full Text] [Related]
5. Blood pressure control in patients with mild to moderate essential hypertension switched from nifedipine gastrointestinal therapeutic system (GITS) 30 mg to nifedipine GITS 20 mg. Toal CB, Canadian Investigators. Clin Ther; 2001 Jan; 23(1):87-96. PubMed ID: 11219482 [Abstract] [Full Text] [Related]
6. Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring. Defina LF, Bookstaver DA, Goldfinger MP, Coffey TA. Ann Pharmacother; 1997 Jan; 31(7-8):819-22. PubMed ID: 9220037 [Abstract] [Full Text] [Related]
9. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group. Zanchetti A. J Hypertens Suppl; 1994 Jul; 12(5):S23-7. PubMed ID: 7965282 [Abstract] [Full Text] [Related]
12. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine. Kes S, Caglar N, Canberk A, Deger N, Demirtas M, Dortlemez H, Kiliccioglu B, Kozan O, Ovunc K, Turkoglu C. Curr Med Res Opin; 2003 Jul; 19(3):226-37. PubMed ID: 12803737 [Abstract] [Full Text] [Related]
13. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. White WB, Black HR, Weber MA, Elliott WJ, Bryzinski B, Fakouhi TD. Am J Cardiol; 1998 Feb 15; 81(4):424-31. PubMed ID: 9485131 [Abstract] [Full Text] [Related]
14. The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Adalat CC Cooperative Study Group. Mac Carthy EP, Pettis PP, Gibson L, Schwartz L, Feig PU. Clin Ther; 1993 Feb 15; 15(6):976-87. PubMed ID: 8111817 [Abstract] [Full Text] [Related]
17. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension. Kirby BJ, Kitchin NR. Int J Clin Pract; 1999 Feb 15; 53(5):339-43. PubMed ID: 10695096 [Abstract] [Full Text] [Related]